(Q41736474)

8 October 2017

1 reference

title

Azimilide dihydrochloride, a novel antiarrhythmic agent (English)

1 reference

8 October 2017

R Karam

1

1 reference

8 October 2017

S Marcello

2

1 reference

8 October 2017

R R Brooks

3

1 reference

8 October 2017

A E Corey

4

1 reference

8 October 2017

A Moore

5

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

American Journal of Cardiology

8 October 2017

1 reference

8 October 2017

81

1 reference

8 October 2017

6A

1 reference

8 October 2017

40D-46D

1 reference

Two components of delayed rectifier current in canine atrium and ventricle. Does IKs play a role in the reverse rate dependence of class III agents?

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900152-0

The novel class III antiarrhythmics NE-10064 and NE-10133 inhibit IsK channels expressed in Xenopus oocytes and IKs in guinea pig cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900152-0

Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900152-0

Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: dependence on blockade of K, Ca, and Na channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900152-0

Comparison of the cardiac electrophysiologic effects of NE-10064 with sotalol and E-4031 and their modification by simulated ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900152-0

Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900152-0

Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900152-0

Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900152-0

Effects of azimilide dihydrochloride on circus movement atrial flutter in the canine sterile pericarditis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900152-0

Effect of age and gender on azimilide pharmacokinetics after a single oral dose of azimilide dihydrochloride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900152-0

10.1016/S0002-9149(98)00152-0

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference